Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Cabergoline or its saltsPDL I DEC / 13
Cabotegravir or its saltsPDL I JUL / 20
Cabozantinib or its saltsPDL I NOV / 18
CalcifediolPDL I JUL / 18
CalcipotriolPDL I DEC / 13
CalcitoninPDL I DEC / 13
CalcitriolPDL I DEC / 13
Calcium bromidePDL I DEC / 13
Calcium bromolactobionatePDL I DEC / 13
Calcium carbimidePDL I DEC / 13
Calcium chloride in injectable form for parenteral nutrition I JAN / 03
Calcium disodium edetate II SEP / 98
Calcium gluconate in injectable form for parenteral nutrition I JAN / 03
Calcium polycarbophil III SEP / 98
Calcium salts when sold for the treatment of hyperphosphatemiaPDL I DEC / 13
Camphor in oleaginous vehicles and in liquid forms in concentrations greater than 11% II OCT / 98
CanagliflozinPDL I JUL / 14
CanakinumabPDL I DEC / 13
Candesartan or its salts or derivativesPDL

including but not limited to candesartan cilexetil

I DEC / 13
Candicidin or its salts or derivativesPDL I DEC / 13
Cantharides, their preparations and derivatives II SEP / 98
CaplacizumabPDL I JUL / 20
Capreomycin or its salts or derivativesPDL I DEC / 13
Captodiamine or its saltsPDL I DEC / 13
Captopril or its saltsPDL I DEC / 13
CarbacholPDL I DEC / 13
CarbamazepinePDL I DEC / 13
Carbapenem salts or derivativesPDL

Including but not limited to: Doripenem, ertapenem, imipenem, meropenem

I DEC / 18
Carbenoxolone or its saltsPDL I DEC / 13
Carbetocin or its saltsPDL I DEC / 13
Carbidopa or its saltsPDL I DEC / 13
CarbimazolePDL I DEC / 13
Carbinoxamine or its salts III SEP / 98
CarbocisteinePDL I DEC / 13
Carbomycin or its salts or derivativesPDL I DEC / 13
CarboplatinPDL I DEC / 13
CarbromalPDL I DEC / 13
CarfilzomibPDL I AUG / 16
Carglumic acid or its salts or derivativesPDL I JUN / 15
CarisoprodolPDL I DEC / 13
CarmustinePDL I DEC / 13
Carphenazine or its saltsPDL I DEC / 13
Carprofen or its salts or derivativesPDL I DEC / 13
Carvedilol and its saltsPDL I DEC / 13
CasirivimabPDL I JUN / 21
Caspofungin or its salts or derivativesPDL I DEC / 13
CatumaxomabPDL I DEC / 13
Cedazuridine PDL

When used in combination with another drug. 

I SEP / 20
Celecoxib or its saltsPDL I DEC / 13
CemiplimabPDL I JUL / 19
CenegerminPDL I MAR / 19
Cephalosporin C or its salts or derivatives or analogsPDL

Including but not limited to: Cephalexin (cefalexin), cephapirin (cefapirin), cefaclor, cefadroxil, cefazolin, cefonicide, cefoxitin, cefprozil, cefuroxime, loracarbef, cefdinir, cefixime, cefoperazone, cefotaxime, cefpodoxime proxetil, ceftazidime, ceftibuten, ceftriaxone, cefepime, ceftobiprole, ceftolozane, cefovecin, ceftiofur

I DEC / 18
Cerapon III SEP / 98
Ceritinib or its saltsPDL I MAY / 15
Cerivastatin or its saltsPDL I DEC / 13
Cerliponase alfaPDL I FEB / 19
Certolizumab pegolPDL I DEC / 13
Cetirizine or its saltsPDL

see hydroxyzine or its salts or derivatives

I DEC / 13
Cetirizine or its salts. in concentrations of 10 mg equivalent to 8.5 mg or less of cetirizine base per dosage unit, in products marketed for pediatric use (under 12 years of age) III JUL / 02
Cetirizine or its salts..

in concentrations of 10mg equivalent to 8.5mg or less of cetirizine base per dosage unit) in products marketed for adult use (age 12 and over)

U JUL / 02
Cetrorelix or its saltsPDL I DEC / 13
CetuximabPDL I DEC / 13
Charcoal (activated) except for use in poisoning treatment U JUN / 98
Charcoal [activated] for use in poisoning treatment II SEP / 98
Chlophedianol and its salts

Clofedanol.

III SEP / 98
ChloralPDL I DEC / 13
Chloral hydratePDL I DEC / 13
ChloralformamidePDL I DEC / 13
ChloralimidePDL I DEC / 13
Chlorambucil or its salts or derivativesPDL I DEC / 13
Chloramphenicol or its salts or derivativesPDL I DEC / 13
Chlorcyclizine or its saltsPDL

except in preparations for external use

I DEC / 13
Chlorhexidine or its saltsPDL

for human use when used as a topical oral preparation

I DEC / 13
Chlorisondamine or its saltsPDL I DEC / 13
ChlormezanonePDL I DEC / 13
Chloroprocaine and its salts for parenteral or ophthalmic use II SEP / 98
Chloroprocaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Chloroquine or its saltsPDL I DEC / 13
Chlorothiazide or its salts or derivativesPDL

for human use

I DEC / 13
Chlorpheniramine and its salts and preparations U AUG / 97
Chlorphentermine and any salt thereofC I JUN / 02
Chlorpromazine or its saltsPDL

for human use

I DEC / 13
ChlorpropamidePDL I DEC / 13
Chlorprothixene or its saltsPDL I DEC / 13
Chlortetracycline or its saltsPDL

For veterinary use

I DEC / 18
Chlorzoxazone and its salts III SEP / 98
Cholecystokinin II SEP / 98
Cholera vaccine except oral, inactivated, when used for prophylaxis against travellers' diarrhea & due to enterotoxigenic escherichia coli (ETEC) I JAN / 04
Cholera vaccine (oral, inactivated) when used for prophylaxis against travellers' diarrhea & due to enterotoxigenic escherichia coli (ETEC) II JAN / 04
Cholestyramine resinPDL

for human use

I DEC / 13
Choline bitartrate parenteral II SEP / 98
Choline salicylatePDL

when sold in combination with magnesium salicylate

I DEC / 13
Choline theophyllinatePDL I DEC / 13
Choriogonadotropin alfaPDL I DEC / 13
Chromium Chloride (chromic chloride) in injectable form for parenteral nutrition I JAN / 03
Chymopapain parenteral II SEP / 98
Chymotrypsin parenteral and ophthalmic II SEP / 98
CiclesonidePDL

For veterinary use

I JUL / 20
Ciclopirox or its saltsPDL I DEC / 13
Cidofovir or its salts or its derivativesPDL I MAY / 18
Cilastatin or its saltsPDL I DEC / 13
Cilazapril or its salts or derivativesPDL I DEC / 13
Cimetidine or its saltsPDL

for veterinary use

I DEC / 13
Cimetidine or its salts.PDL

except when sold in concentrations of 200 milligrams or less per oral dosage unit and indicated for the treatment of heartburn

I DEC / 13
Cimetidine or its salts..

when sold in concentrations of 100 mg or less per dosage unit and indicated for the treatment of heartburn

III DEC / 13
Cinacalcet or its saltsPDL I DEC / 13
Cinchocaine (dibucaine) and its salts for ophthalmic or parenteral use II SEP / 98
Cinchophene or its saltsPDL I DEC / 13
Cinnamedrine U
CinoxacinPDL I DEC / 13
Ciprofloxacin or its saltsPDL I DEC / 13
Cisapride or its saltsPDL I SEP / 98
Cisatracurium besilatePDL I DEC / 13
CisplatinPDL I DEC / 13
Citalopram or its saltsPDL I DEC / 13
Cladribine or its salts or derivativesPDL I DEC / 13
Clemastine and its salts III SEP / 98
Clenbuterol or its saltsPDL I DEC / 13
Clevidipine or its saltsPDL I DEC / 13
Clidinium and its salts II SEP / 98
Clobetasone butyrate when sold in a concentration of 0.05% clobetasone butyrate in cream preparations for topical use on the skin II OCT / 06
Clodronic acid or its saltsPDL I DEC / 13
ClofarabinePDL I DEC / 13
ClofibratePDL I DEC / 13
Clomiphene or its saltsPDL I DEC / 13
Clomipramine or its saltsPDL I DEC / 13
Clonidine or its saltsPDL I DEC / 13
Clopidogrel or its saltsPDL I DEC / 13
Clorazepic acid or its saltsPDL I DEC / 13
Closantel or its saltsPDL

for veterinary use, including but not limited to closantel sodium

I AUG / 16
Clotiazepam and any salt thereofTS I JUN / 02
Clotrimazole and its salts.. for human use in preparations for topical use U DEC / 13
Clotrimazole or its saltsPDL

for human use, except in preparations for topical or vaginal use

I DEC / 13
Clotrimazole or its salts.

for human use in preparations for intra-vaginal use

III DEC / 13
Clozapine or its saltsPDL I DEC / 13
Coal tar in concentrations of more than 10% II SEP / 98
Coal tar. in concentrations up to and including 10% U
Cobicistat or its saltsPDL I DEC / 18
Cobimetinib or its saltsPDL I AUG / 16
Coca (Erythroxylum), its preparations, derivatives, alkaloids and saltsN

Including: Coca leaves; Cocaine; Ecgonine; but not including 123l-ioflupane
 

I JUN / 02
Codeine and its salts in preparations exempted from the Regulations to the Controlled Drugs and Substances Act II SEP / 98
ColchicinePDL I DEC / 13
Colesevelam or its saltsPDL

including but not limited to colesevelam hydrochloride

I DEC / 13
Colestipol or its saltsPDL I DEC / 13
Colfosceril or its derivativesPDL I DEC / 13
Colistin or its salt or derivativesPDL

including but not limited to colistimethate

I DEC / 13
CollagenasePDL

when recommended for the debridement of severe burns and skin ulcers

I DEC / 13
Copper chloride (cupric chloride) in injectable form for parenteral nutrition I JAN / 03
Copper sulfate in injectable form for parenteral nutrition I JAN / 03
CrisaborolePDL I JUL / 18
Crizotinib or its salts or derivativesPDL I DEC / 13
Cromoglicic (cromoglycic) acid or its saltsPDL

except sodium cromoglicate (cromoglycate) in solutions for ophthalmic or nasal use in concentrations of 2% or less [*see sodium cromoglicate (cromoglycate)]

I DEC / 13
Crotamiton II SEP / 98
Cyclandelate II SEP / 98
Cyclazocine and its salts II SEP / 98
CyclizinePDL

for human use

I DEC / 13
Cyclobenzaprine or its saltsPDL I DEC / 13
Cyclomethacaine and its salts for ophthalmic or parenteral use II SEP / 98
Cyclopentamine and its salts II SEP / 98
Cyclopentolate or its salts except in products for ophthalmic or parenteral use II SEP / 98
Cyclopentolate or its saltsPDL

in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada

I DEC / 13
CyclophosphamidePDL I DEC / 13
CycloserinePDL I DEC / 13
CyclosporinePDL

including but not limited to ciclosporin

I DEC / 13
Cyproheptadine and its salts II SEP / 98
Cyproterone acetatePDL

including but not limited to cyproterone acetate

I DEC / 13
Cysteamine (Mercaptamine) or its saltsPDL I AUG / 17
Cytarabine or its saltsPDL I DEC / 13
Cytomegalovirus immune globulins I FEB / 02

169 résultats

Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act